CERS vs MAS · rev $201.3M vs P/E 18, rev $7.83B
Cerus Corporation (CERS) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
CERS currently screens at market cap $294.4M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the CERS and MAS stock pages for the full models.
Not investment advice.